Francis Schneider
- Internal Medicine top 0.5%
- Infectious Diseases top 0.5%
- Neurology top 0.5%
- Long-Term Effects of COVID-19 7
- Microbiology top 2%
- Antimicrobial Peptides and Activities 11
-
- Sepsis Diagnosis and Treatment 16
-
- Nitric Oxide and Endothelin Effects 8
-
- Biochemical and Structural Characterization 7
- Nicotinic Acetylcholine Receptors Study 7
-
- Liver Disease and Transplantation 7
-
- Neuropeptides and Animal Physiology 6
Francis Schneider
106 papers receiving 5.1k citations
Hit Papers
Peers
Comparison fields: 5 of 146
- Internal Medicine 707
- Infectious Diseases 2.1k
- Neurology 1.3k
- Critical Care and Intensive Care Medicine 383
- Microbiology 199
Countries citing papers authored by Francis Schneider
This map shows the geographic impact of Francis Schneider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francis Schneider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francis Schneider more than expected).
Fields of papers citing papers by Francis Schneider
This network shows the impact of papers produced by Francis Schneider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francis Schneider. The network helps show where Francis Schneider may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Francis Schneider, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 4 | |
| 3 | 2023 | 14 | |
| 4 | 2022 | 0 | |
| 5 | 2022 | 9 | |
| 6 | 2022 | 8 | |
| 7 | 2022 | 2 | |
| 8 | 2021 | 25 | |
| 9 | 2021 | 2 | |
| 10 | 2020 | 239 | |
| 11 | 2019 | 4 | |
| 12 | 2018 | 24 | |
| 13 | 2017 | 33 | |
| 14 | 2013 | 35 | |
| 15 | 2010 | 1 | |
| 16 | 2009 | 84 | |
| 17 | 2006 | 122 | |
| 18 | 2006 | 83 | |
| 19 | 2003 | 1 | |
| 20 | 1997 | 55 |
About Francis Schneider
Francis Schneider is a scholar working on Microbiology, Critical Care and Intensive Care Medicine and Epidemiology, having authored 110 papers that have together received 5.2k indexed citations. Recurring topics across this work include Sepsis Diagnosis and Treatment (16 papers), Antimicrobial Peptides and Activities (11 papers), Nitric Oxide and Endothelin Effects (8 papers), Biochemical and Structural Characterization (7 papers), Long-Term Effects of COVID-19 (7 papers), Liver Disease and Transplantation (7 papers), Nicotinic Acetylcholine Receptors Study (7 papers) and Neuropeptides and Animal Physiology (6 papers). The work is most often cited by research in Internal Medicine (707 citations), Infectious Diseases (2.1k citations) and Neurology (1.3k citations). Francis Schneider has collaborated with scholars based in France, Italy and Germany. Frequent co-authors include Julie Helms, François Séverac, Mickaël Ohana, Ferhat Meziani, Vincent Castelain, Xavier Delabranche, Ian Léonard-Lorant, Samira Fafi‐Kremer, M. Schenck and Hamid Merdji. Their work appears in journals such as Proceedings of the National Academy of Sciences, JAMA and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.